Aromataseinhibitors indications The term "aromatase inhibitor peptide" can refer to a few distinct concepts, but at its core, it relates to substances that interfere with the aromatase enzyme's function. Aromatase is crucial for converting androgens into estrogens. The most common context for aromatase inhibitors (AIs) is in medicine, particularly for treating hormone-receptor-positive breast cancer in postmenopausal women, where reducing estrogen levels is a primary therapeutic goal.Aromatase inhibitors release calcitonin gene-related ... However, the term can also encompass synthetic peptides designed to block aromatase activity for research purposes or potentially as novel therapeutic agents.CYP19A1 blocking peptide (DAG-P1390), manufactured by Creative Diagnostics with high sensitivity, specificity, and reproducibility.
Aromatase inhibitors are a class of drugs or compounds that reduce the amount of estrogen produced by the body.Anastrozole (ZD1033) | Aromatase Inhibitor They achieve this by blocking the activity of the aromatase enzyme (also known as cytochrome P450 19A1 or CYP19A1). This enzyme is responsible for the final step in estrogen biosynthesis, converting androstenedione into estrone and testosterone into estradiol. By inhibiting aromatase, these compounds effectively lower circulating estrogen levels.
Aromatase inhibitors are broadly categorized into two main types:
* Steroidal Aromatase Inhibitors: These compounds, like exemestane, irreversibly inhibit the aromatase enzyme. They bind covalently to the enzyme's active site, preventing the substrate from accessing it and thus permanently deactivating the enzyme作者：D Parish·2001·被引用次数：2—Results from this study suggest that itmay be possible to develop small peptidesto inhibit cytokine-stimulated aromatase activity in a tissue-specific manner..
* Non-Steroidal Aromatase Inhibitors: This group, which includes widely used drugs like anastrozole and letrozole, reversibly inhibits the aromatase enzyme2021年12月16日—In large studies,both anastrozole and exemestanehave been shown to lower breast cancer risk in postmenopausal women who are at increased risk.. They bind to the enzyme's active site but do not form a permanent bond, allowing for potential recovery of enzyme activity over time. Anastrozole, for instance, is known for its potent and highly selective inhibition of human placental aromatase.
The term "aromatase inhibitor peptide" can specifically refer to synthetic peptides engineered to interact with and block the aromatase enzymeAromatase Peptide (P2584). These peptides are often developed for research applications. For example, some synthetic peptides are designed based on specific amino acid regions of the human aromatase protein, such as those within amino acid regions 400-450. These can be used as blocking peptides in immunoassays or to study enzyme function. Research has also explored naturally occurring peptides, such as seed-derived peptide lunasin, which has shown potential in suppressing breast cancer cell growth by regulating aromatase activity and other inflammatory mediators. Furthermore, studies suggest the possibility of developing small peptides to inhibit cytokine-stimulated aromatase activity in a tissue-specific manner.
The primary clinical application of aromatase inhibitors is in the treatment of hormone-receptor-positive breast cancer in postmenopausal women. By significantly reducing estrogen production, AIs help to slow or stop the growth of estrogen-dependent cancer cells. They are also used in settings where reducing breast cancer risk is a goal for high-risk individuals.作者：D Parish·2001·被引用次数：2—Results from this study suggest that itmay be possible to develop small peptidesto inhibit cytokine-stimulated aromatase activity in a tissue-specific manner. While effective, aromatase inhibitors can have side effects, and the choice of which AI to use, and its associated side effects, is a consideration in treatment decisions.
* Hormone Therapy: Aromatase inhibitors are a form of hormone therapy, a treatment that targets hormones that fuel cancer growth.作者：DM El-Kersh·2021·被引用次数：77—Hence,aromatase inhibitors prevent extragonadal estrogen biosynthesisplaying an important role in the management of estrogen-dependent breast ...
* Estrogen Blockers: Aromatase inhibitors are a type of estrogen blocker, though other types of hormone therapies, like tamoxifen, also act as anti-estrogens by blocking estrogen receptors.
* Natural Aromatase Inhibitors: Beyond pharmaceuticals and synthetic peptides, some natural compounds derived from sources like citrus peels are being investigated for their aromatase inhibitory activitiesAnastrozole is a potent, highly selective aromatase inhibitor, which inhibits human placental aromatase with an IC 50 of 15 nM..
* Research Tools: Beyond therapeutic uses, peptides related to aromatase, such as antibodies and blocking peptides, are valuable tools in biochemical research to understand enzyme function, steroidogenesis, and related biological pathways.
In summary, "aromatase inhibitor peptide" encompasses both therapeutic agents and research tools that target the aromatase enzyme.Seed-derived peptide lunasin suppressed breast cancer ... While pharmaceutical aromatase inhibitors like anastrozole and exemestane are well-established treatments, the development and use of specific peptides for aromatase inhibition represent an ongoing area of scientific exploration.
Join the newsletter to receive news, updates, new products and freebies in your inbox.